Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by Dwizellon Sep 25, 2019 1:15pm

214 Views

Post# 30163594

RE:~3K Shares Traded...

mattw1100 wrote: Jeesh

Ridiculous ! And this major pressure from the sellers (!) makes the SP to lose 2% !

Like JFM said the canadian marcket give up on th ... I realy hope the Nasdaq listing will change this state.

---------

Tomorrow it will be 2 months since de recomandation from the comitee in europe ... will we have the approval this week ? It could help a little .. or not.

Bullboard Posts

Who, why, and what of the great "Crypto Surge"